Cite
HARVARD Citation
Lastraioli, E. et al. (2020). Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer. Anti-cancer drugs. 31 (9), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lastraioli, E. et al. (2020). Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer. Anti-cancer drugs. 31 (9), p. . [Online].